RAC1 and endothelial dysfunction: Accordingly, these emerging data may have applicative/translational implications because Rac1 inhibition may represent a potential therapeutic intervention to reduce human endothelial dysfunction and subsequently vascular diseases in several clinical scenarios, particularly vein‐related diseases.